Healthcare M&A Faces an Interesting Dichotomy

The healthcare landscape faced an intriguing scenario of transitions and valuation dilemmas in the first half of 2025, marking a shift from the previous year’s trends. Hospital and health system mergers and acquisitions experienced a slower start, mainly due to economic uncertainties and global trade issues. However, the recent enactment of the One Big Beautiful Bill Act provided a level of clarity that could potentially catalyze M&A activities. This clarity might lead to a ‘dichotomy’ in the merger landscape, where some organizations hasten to find partners in response to financial challenges, while others adopt a cautious stance to navigate the evolving healthcare environment.

Kaufman Hall, a renowned healthcare consulting firm, anticipates an acceleration in hospital and health system M&A post the legislative changes. Yet, it expects the pace of transactions to be relatively measured as healthcare players absorb the impacts of the shifting policy landscape. The second quarter of 2025 saw a ‘modest’ uptick in M&A activities, with eight deals announced compared to five in the prior quarter. Despite this increase, the second quarter’s M&A figures remained below historical averages, raising questions about the industry’s trajectory.

Of the deals announced in Q2, nearly half involved divestitures, reflecting a wider realignment process in the market for both for-profit and not-for-profit healthcare systems. Moreover, all eight deals had nonprofit organizations as acquirers, with three being religiously affiliated, and one governmentally owned. Notably, there were no mega mergers exceeding $1 billion in annual revenue in the second quarter, highlighting a shift from past trends in deal sizes.

An illustrative case from the second quarter not featured in Kaufman Hall’s report was the acquisition agreement between Ascension and AmSurg. This strategic move by Ascension emphasized a shift towards lower-cost patient care through the acquisition of over 250 ASC facilities. The deal typified the ongoing trend of healthcare systems seeking out non-acute spaces for growth and transformation, aligning with the broader industry’s movement towards innovative care delivery models.

Looking ahead, as care delivery models evolve and the focus shifts to accessible and cost-effective healthcare solutions, health systems need to adapt swiftly to stay competitive. The evolving M&A landscape in healthcare presents both challenges and opportunities for organizations seeking growth and sustainability in a dynamic market environment. As policy changes take effect and the industry adjusts to new realities, strategic partnerships and acquisitions will play a crucial role in shaping the future of healthcare delivery.